Platycodin D enhances LDLR expression and LDL uptake via down-regulation of IDOL mRNA in hepatic cells.

Scientific Reports
Yu-Jeong ChoiSeong-Gyu Ko

Abstract

The root of Platycodon grandiflorum (PG) has long been used as a traditional herbal medicine in Asian country. Platycondin D (PD), triterpenoid saponin that is a main constituent of PG, exhibits various biological activities such as anti-inflammatory, anti-oxidant, anti-diabetic, and anti-cancer effects. A previous study showed that PD had cholesterol-lowering effects in mice that develop hypercholesterolemia, but the underlying molecular mechanisms have not been elucidated during the last decade. Here, we demonstrated that both PG and PD markedly increased levels of cell surface low-density lipoprotein receptor (LDLR) by down-regulation of the E3 ubiquitin ligase named inducible degrader of the LDLR (IDOL) mRNA, leading to the enhanced uptake of LDL-derived cholesterol (LDL-C) in hepatic cells. Furthermore, cycloheximide chase analysis and in vivo ubiquitination assay revealed that PD increased the half-life of LDLR protein by reducing IDOL-mediated LDLR ubiquitination. Finally, we demonstrated that treatment of HepG2 cells with simvastatin in combination with PG and PD had synergistic effects on the improvement of LDLR expression and LDL-C uptake. Together, these results provide the first molecular evidence for anti-hyperchol...Continue Reading

References

Feb 1, 1990·Nature·J L Goldstein, M S Brown
Dec 1, 2001·Nature Medicine·D J Rader
Nov 9, 2002·The American Journal of Cardiology·Claude GagnéUNKNOWN Ezetimibe Study Group
Apr 27, 2005·International Journal of Obesity : Journal of the International Association for the Study of Obesity·H L ZhaoY S Kim
Jan 18, 2006·Cell·Joseph L GoldsteinMichael S Brown
Apr 22, 2006·European Journal of Pharmacology·Hai Lin ZhaoYeong Shik Kim
Jul 9, 2009·International Journal of Biological Sciences·Tyler F DanielsZhihua Jiang
Aug 6, 2010·Nature·Tanya M TeslovichSekar Kathiresan
Sep 17, 2010·Trends in Cell Biology·Theodore L Steck, Yvonne Lange
Sep 25, 2010·Arteriosclerosis, Thrombosis, and Vascular Biology·Dawn M WaterworthManjinder S Sandhu
Dec 1, 2011·Toxicological Research·Won-Ho LeeSeong-Hun Choi
Oct 14, 2014·Accounts of Chemical Research·Martin R Krause, Steven L Regen
Dec 3, 2014·Cell Metabolism·Cynthia HongPeter Tontonoz
Feb 6, 2016·Circulation Research·Andrew J Brown, Joanne Hsieh
Mar 20, 2016·Chemistry and Physics of Lipids·Vicky HoweAndrew J Brown
Mar 18, 2017·The New England Journal of Medicine·Marc S SabatineUNKNOWN FOURIER Steering Committee and Investigators
Aug 16, 2017·Journal of Agricultural and Food Chemistry·Shih-Fen ChenJui-Hung Yen
Aug 28, 2018·Biochemical and Biophysical Research Communications·Yi WangGongning Shi
Sep 19, 2018·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Shakti Prasad PattanayakAntonio Lapenna
Sep 28, 2018·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Cheng-Lin FuWei Li
Nov 8, 2018·The New England Journal of Medicine·Gregory G SchwartzUNKNOWN ODYSSEY OUTCOMES Committees and Investigators
May 18, 2019·Expert Opinion on Drug Safety·Larysa StrilchukArrigo Fg Cicero

❮ Previous
Next ❯

Citations

Apr 4, 2021·International Journal of Molecular Sciences·Giuseppe ManninoCarla Gentile

❮ Previous
Next ❯

Methods Mentioned

BETA
ELISA
PCR
confocal microscopy
flow cytometry
Assay
ubiquitination

Software Mentioned

CellQuest Pro
Image J

Related Concepts

Related Feeds

ApoE, Lipids & Cholesterol

Serum cholesterol, triglycerides, apolipoprotein B (APOB)-containing lipoproteins (very low-density lipoprotein (VLDL), immediate-density lipoprotein (IDL), and low-density lipoprotein (LDL), lipoprotein A (LPA)) and the total cholesterol/high-density lipoprotein (HDL) cholesterol ratio are all connected in diseases. Here is the latest research.